ECS Botanics Holdings Ltd. provided revenue guidance for the third quarter of fiscal year 2022. The expected revenue increase during the current quarter will highlight a 39% increase on the previous quarter (second quarter of fiscal year 2022: $1,434,000) and a 440% rise on the prior corresponding period (second quarter of fiscal year 2021: $371,000). It would also mark another consecutive quarter of growth for the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.019 AUD | +5.56% | +5.56% | -15.56% |
05-17 | ECS Botanics Secures First B2C Medicinal Cannabis Contract | MT |
02-27 | ECS Botanics Holdings Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.56% | 15.4M | |
-.--% | 339M | |
+41.56% | 277M | |
+22.68% | 253M | |
+48.84% | 194M | |
+145.74% | 144M | |
+46.30% | 132M | |
-39.97% | 123M | |
-28.57% | 121M | |
+7.69% | 93.71M |
- Stock Market
- Equities
- ECS Stock
- News ECS Botanics Holdings Ltd
- ECS Botanics Holdings Ltd Provides Revenue Guidance for the Third Quarter of Fiscal Year 2022